Is it teething time for your little one?

 

She is known for keeping her personal life private, but there was one issue that Sarah Jessica Parker just could not stay silent over this week.

 

The Sex and the City star has cut ties with a pharmaceutical company she was fronting an allergy campaign for, after it hiked up the cost of its life-saving EpiPens.

 

The mother-of-three took to Instagram to reveal that she had ended her working relationship with Mylan, after it raised the price of its EpiPen treatment for anaphylaxis to a whopping $600 (around €535).

 

 

A photo posted by SJP (@sarahjessicaparker) on

 

In the post, the 51-year-old revealed that she got involved with the company on account of her son James’ ‘life-threatening peanut allergy’, explaining: “The Epinephrine Auto-Injector is a vital part of our family’s healthcare, as it is for the many who are at risk.”

 

Once word of the exorbitant price hike reached her, however, Sarah said she felt compelled to resign as a paid spokeswoman for the company.

 

“[It] renders the medication cost-prohibitive for countless people,” she wrote, adding that she is ‘disappointed, saddened and deeply concerned by Mylan’s actions’.

 

 

She went on to appeal to the company to reverse its decision, for the sake of families who depend so heavily on the EpiPen.

 

"I hope they will seriously consider the outpouring of voices of those millions of people who are dependent on the device, and take swift action to lower the cost to be more affordable for whom it is a life-saving necessity,” she added.

 

Fair play to Sarah for taking a stand. We hope her words will have an impact on the company’s next step.

 

SHARE if you have a new-found respect for the famous mum-of-three.

Latest

Trending

Hello Mama!
Help us help you by allowing us and our partners to remember your device as having browsed MummyPages and serve you better content and ads

We're on a mission to help our mums and their families thrive by informing, connecting and entertaining.

Join us in our mission by consenting to the use of cookies and IP address recognition by us and our partners to serve you content (including ads) best suited to your interests, both here and around the web.

We promise never to share any other information that may be deemed personal unless you explicitly tell us it's ok.

If you want more info, see our privacy policy.